prostate cancer
Item
low or intermediate risk prostate cancer patients as defined by:
boolean
C0600139 (UMLS CUI [1])
tumor stage; gleason score; prostate specific antigen
Item
clinical stage t1-2b, gleason score <=7, and psa <=20 ng/ml
boolean
C1300072 (UMLS CUI [1])
C3203027 (UMLS CUI [2])
C0138741 (UMLS CUI [3])
age
Item
age >= 18 years
boolean
C0001779 (UMLS CUI [1])
Antiandrogen therapy
Item
androgen deprivation therapy (lhrh-agonists or antiandrogens) >6 months
boolean
C0279492 (UMLS CUI [1])
pelvic radiotherapy
Item
prior pelvic radiotherapy
boolean
C0436276 (UMLS CUI [1])
anticoagulation medication
Item
anticoagulation medication (if unsafe to discontinue for gold seed insertion)
boolean
C0003280 (UMLS CUI [1])
bleeding diathesis
Item
diagnosis of bleeding diathesis
boolean
C0005779 (UMLS CUI [1])
large prostate
Item
large prostate (>90cm3) on imaging
boolean
C0426732 (UMLS CUI [1])
immunosuppressive medications
Item
immunosuppressive medications
boolean
C0021081 (UMLS CUI [1])
inflammatory bowel disease
Item
inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])